nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—ABCG2—Dactinomycin—testicular cancer	0.0993	0.137	CbGbCtD
Pantoprazole—ABCG2—Carboplatin—testicular cancer	0.0667	0.0919	CbGbCtD
Pantoprazole—ABCG2—Cisplatin—testicular cancer	0.057	0.0785	CbGbCtD
Pantoprazole—ABCG2—Etoposide—testicular cancer	0.056	0.0771	CbGbCtD
Pantoprazole—CYP2C19—Ifosfamide—testicular cancer	0.0524	0.0721	CbGbCtD
Pantoprazole—SLCO1B1—Methotrexate—testicular cancer	0.0466	0.0642	CbGbCtD
Pantoprazole—CYP2C9—Ifosfamide—testicular cancer	0.0436	0.06	CbGbCtD
Pantoprazole—ABCG2—Doxorubicin—testicular cancer	0.0382	0.0526	CbGbCtD
Pantoprazole—ABCG2—Methotrexate—testicular cancer	0.037	0.051	CbGbCtD
Pantoprazole—ABCB1—Dactinomycin—testicular cancer	0.0358	0.0493	CbGbCtD
Pantoprazole—CYP3A4—Ifosfamide—testicular cancer	0.0253	0.0349	CbGbCtD
Pantoprazole—CYP1A2—Etoposide—testicular cancer	0.0231	0.0318	CbGbCtD
Pantoprazole—ABCB1—Vinblastine—testicular cancer	0.0224	0.0309	CbGbCtD
Pantoprazole—CYP2C9—Cisplatin—testicular cancer	0.0212	0.0292	CbGbCtD
Pantoprazole—ABCB1—Cisplatin—testicular cancer	0.0206	0.0283	CbGbCtD
Pantoprazole—ABCB1—Etoposide—testicular cancer	0.0202	0.0278	CbGbCtD
Pantoprazole—ABCB1—Doxorubicin—testicular cancer	0.0138	0.019	CbGbCtD
Pantoprazole—CYP3A4—Vinblastine—testicular cancer	0.0134	0.0185	CbGbCtD
Pantoprazole—ABCB1—Methotrexate—testicular cancer	0.0133	0.0184	CbGbCtD
Pantoprazole—CYP3A4—Etoposide—testicular cancer	0.0121	0.0167	CbGbCtD
Pantoprazole—CYP3A4—Doxorubicin—testicular cancer	0.00826	0.0114	CbGbCtD
Pantoprazole—Body temperature increased—Etoposide—testicular cancer	0.000134	0.000491	CcSEcCtD
Pantoprazole—Conjunctivitis—Doxorubicin—testicular cancer	0.000134	0.000491	CcSEcCtD
Pantoprazole—Urinary tract infection—Doxorubicin—testicular cancer	0.000134	0.000491	CcSEcCtD
Pantoprazole—Haemorrhage—Epirubicin—testicular cancer	0.000134	0.00049	CcSEcCtD
Pantoprazole—Hepatitis—Epirubicin—testicular cancer	0.000134	0.00049	CcSEcCtD
Pantoprazole—Eye disorder—Methotrexate—testicular cancer	0.000134	0.000489	CcSEcCtD
Pantoprazole—Tinnitus—Methotrexate—testicular cancer	0.000134	0.000488	CcSEcCtD
Pantoprazole—Hypoaesthesia—Epirubicin—testicular cancer	0.000133	0.000487	CcSEcCtD
Pantoprazole—Asthenia—Cisplatin—testicular cancer	0.000133	0.000486	CcSEcCtD
Pantoprazole—Pharyngitis—Epirubicin—testicular cancer	0.000133	0.000486	CcSEcCtD
Pantoprazole—Sweating—Doxorubicin—testicular cancer	0.000132	0.000484	CcSEcCtD
Pantoprazole—Urinary tract disorder—Epirubicin—testicular cancer	0.000132	0.000484	CcSEcCtD
Pantoprazole—Oedema peripheral—Epirubicin—testicular cancer	0.000132	0.000483	CcSEcCtD
Pantoprazole—Haematuria—Doxorubicin—testicular cancer	0.000132	0.000481	CcSEcCtD
Pantoprazole—Connective tissue disorder—Epirubicin—testicular cancer	0.000132	0.000481	CcSEcCtD
Pantoprazole—Urethral disorder—Epirubicin—testicular cancer	0.000131	0.00048	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000131	0.000478	CcSEcCtD
Pantoprazole—Epistaxis—Doxorubicin—testicular cancer	0.00013	0.000476	CcSEcCtD
Pantoprazole—Sinusitis—Doxorubicin—testicular cancer	0.00013	0.000474	CcSEcCtD
Pantoprazole—Immune system disorder—Methotrexate—testicular cancer	0.000129	0.000473	CcSEcCtD
Pantoprazole—Visual impairment—Epirubicin—testicular cancer	0.000129	0.000472	CcSEcCtD
Pantoprazole—Agranulocytosis—Doxorubicin—testicular cancer	0.000129	0.000471	CcSEcCtD
Pantoprazole—Chills—Methotrexate—testicular cancer	0.000128	0.00047	CcSEcCtD
Pantoprazole—Nausea—Ifosfamide—testicular cancer	0.000128	0.000467	CcSEcCtD
Pantoprazole—Diarrhoea—Cisplatin—testicular cancer	0.000127	0.000464	CcSEcCtD
Pantoprazole—Erythema multiforme—Epirubicin—testicular cancer	0.000127	0.000463	CcSEcCtD
Pantoprazole—Alopecia—Methotrexate—testicular cancer	0.000127	0.000463	CcSEcCtD
Pantoprazole—Mental disorder—Methotrexate—testicular cancer	0.000125	0.000459	CcSEcCtD
Pantoprazole—Eye disorder—Epirubicin—testicular cancer	0.000125	0.000458	CcSEcCtD
Pantoprazole—Hypersensitivity—Etoposide—testicular cancer	0.000125	0.000457	CcSEcCtD
Pantoprazole—Tinnitus—Epirubicin—testicular cancer	0.000125	0.000457	CcSEcCtD
Pantoprazole—Malnutrition—Methotrexate—testicular cancer	0.000125	0.000456	CcSEcCtD
Pantoprazole—Haemoglobin—Doxorubicin—testicular cancer	0.000125	0.000456	CcSEcCtD
Pantoprazole—Flushing—Epirubicin—testicular cancer	0.000124	0.000455	CcSEcCtD
Pantoprazole—Rhinitis—Doxorubicin—testicular cancer	0.000124	0.000454	CcSEcCtD
Pantoprazole—Haemorrhage—Doxorubicin—testicular cancer	0.000124	0.000453	CcSEcCtD
Pantoprazole—Hepatitis—Doxorubicin—testicular cancer	0.000124	0.000453	CcSEcCtD
Pantoprazole—Hypoaesthesia—Doxorubicin—testicular cancer	0.000123	0.000451	CcSEcCtD
Pantoprazole—Pharyngitis—Doxorubicin—testicular cancer	0.000123	0.00045	CcSEcCtD
Pantoprazole—Urinary tract disorder—Doxorubicin—testicular cancer	0.000122	0.000448	CcSEcCtD
Pantoprazole—Oedema peripheral—Doxorubicin—testicular cancer	0.000122	0.000447	CcSEcCtD
Pantoprazole—Dysgeusia—Methotrexate—testicular cancer	0.000122	0.000446	CcSEcCtD
Pantoprazole—Asthenia—Etoposide—testicular cancer	0.000122	0.000445	CcSEcCtD
Pantoprazole—Connective tissue disorder—Doxorubicin—testicular cancer	0.000122	0.000445	CcSEcCtD
Pantoprazole—Urethral disorder—Doxorubicin—testicular cancer	0.000122	0.000444	CcSEcCtD
Pantoprazole—Immune system disorder—Epirubicin—testicular cancer	0.000121	0.000442	CcSEcCtD
Pantoprazole—Back pain—Methotrexate—testicular cancer	0.000121	0.000441	CcSEcCtD
Pantoprazole—Chills—Epirubicin—testicular cancer	0.00012	0.00044	CcSEcCtD
Pantoprazole—Pruritus—Etoposide—testicular cancer	0.00012	0.000439	CcSEcCtD
Pantoprazole—Arrhythmia—Epirubicin—testicular cancer	0.00012	0.000438	CcSEcCtD
Pantoprazole—Visual impairment—Doxorubicin—testicular cancer	0.00012	0.000437	CcSEcCtD
Pantoprazole—Alopecia—Epirubicin—testicular cancer	0.000118	0.000433	CcSEcCtD
Pantoprazole—Vomiting—Cisplatin—testicular cancer	0.000118	0.000431	CcSEcCtD
Pantoprazole—Vision blurred—Methotrexate—testicular cancer	0.000117	0.000429	CcSEcCtD
Pantoprazole—Mental disorder—Epirubicin—testicular cancer	0.000117	0.000429	CcSEcCtD
Pantoprazole—Erythema multiforme—Doxorubicin—testicular cancer	0.000117	0.000429	CcSEcCtD
Pantoprazole—Rash—Cisplatin—testicular cancer	0.000117	0.000427	CcSEcCtD
Pantoprazole—Dermatitis—Cisplatin—testicular cancer	0.000117	0.000427	CcSEcCtD
Pantoprazole—Malnutrition—Epirubicin—testicular cancer	0.000117	0.000426	CcSEcCtD
Pantoprazole—Diarrhoea—Etoposide—testicular cancer	0.000116	0.000425	CcSEcCtD
Pantoprazole—Eye disorder—Doxorubicin—testicular cancer	0.000116	0.000424	CcSEcCtD
Pantoprazole—Ill-defined disorder—Methotrexate—testicular cancer	0.000116	0.000423	CcSEcCtD
Pantoprazole—Tinnitus—Doxorubicin—testicular cancer	0.000116	0.000423	CcSEcCtD
Pantoprazole—Anaemia—Methotrexate—testicular cancer	0.000115	0.000421	CcSEcCtD
Pantoprazole—Flushing—Doxorubicin—testicular cancer	0.000115	0.000421	CcSEcCtD
Pantoprazole—Flatulence—Epirubicin—testicular cancer	0.000115	0.00042	CcSEcCtD
Pantoprazole—Tension—Epirubicin—testicular cancer	0.000114	0.000418	CcSEcCtD
Pantoprazole—Dysgeusia—Epirubicin—testicular cancer	0.000114	0.000418	CcSEcCtD
Pantoprazole—Nervousness—Epirubicin—testicular cancer	0.000113	0.000414	CcSEcCtD
Pantoprazole—Back pain—Epirubicin—testicular cancer	0.000113	0.000413	CcSEcCtD
Pantoprazole—Malaise—Methotrexate—testicular cancer	0.000112	0.000411	CcSEcCtD
Pantoprazole—Dizziness—Etoposide—testicular cancer	0.000112	0.000411	CcSEcCtD
Pantoprazole—Muscle spasms—Epirubicin—testicular cancer	0.000112	0.00041	CcSEcCtD
Pantoprazole—Immune system disorder—Doxorubicin—testicular cancer	0.000112	0.000409	CcSEcCtD
Pantoprazole—Vertigo—Methotrexate—testicular cancer	0.000112	0.000409	CcSEcCtD
Pantoprazole—Leukopenia—Methotrexate—testicular cancer	0.000112	0.000408	CcSEcCtD
Pantoprazole—Chills—Doxorubicin—testicular cancer	0.000111	0.000407	CcSEcCtD
Pantoprazole—Arrhythmia—Doxorubicin—testicular cancer	0.000111	0.000405	CcSEcCtD
Pantoprazole—Nausea—Cisplatin—testicular cancer	0.00011	0.000403	CcSEcCtD
Pantoprazole—Vision blurred—Epirubicin—testicular cancer	0.00011	0.000402	CcSEcCtD
Pantoprazole—Alopecia—Doxorubicin—testicular cancer	0.00011	0.000401	CcSEcCtD
Pantoprazole—Cough—Methotrexate—testicular cancer	0.000109	0.000398	CcSEcCtD
Pantoprazole—Mental disorder—Doxorubicin—testicular cancer	0.000109	0.000397	CcSEcCtD
Pantoprazole—Ill-defined disorder—Epirubicin—testicular cancer	0.000108	0.000396	CcSEcCtD
Pantoprazole—Convulsion—Methotrexate—testicular cancer	0.000108	0.000395	CcSEcCtD
Pantoprazole—Vomiting—Etoposide—testicular cancer	0.000108	0.000395	CcSEcCtD
Pantoprazole—Malnutrition—Doxorubicin—testicular cancer	0.000108	0.000395	CcSEcCtD
Pantoprazole—Anaemia—Epirubicin—testicular cancer	0.000108	0.000394	CcSEcCtD
Pantoprazole—Agitation—Epirubicin—testicular cancer	0.000107	0.000392	CcSEcCtD
Pantoprazole—Rash—Etoposide—testicular cancer	0.000107	0.000391	CcSEcCtD
Pantoprazole—Dermatitis—Etoposide—testicular cancer	0.000107	0.000391	CcSEcCtD
Pantoprazole—Headache—Etoposide—testicular cancer	0.000106	0.000389	CcSEcCtD
Pantoprazole—Flatulence—Doxorubicin—testicular cancer	0.000106	0.000389	CcSEcCtD
Pantoprazole—Chest pain—Methotrexate—testicular cancer	0.000106	0.000388	CcSEcCtD
Pantoprazole—Myalgia—Methotrexate—testicular cancer	0.000106	0.000388	CcSEcCtD
Pantoprazole—Arthralgia—Methotrexate—testicular cancer	0.000106	0.000388	CcSEcCtD
Pantoprazole—Tension—Doxorubicin—testicular cancer	0.000106	0.000387	CcSEcCtD
Pantoprazole—Dysgeusia—Doxorubicin—testicular cancer	0.000106	0.000386	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000105	0.000385	CcSEcCtD
Pantoprazole—Malaise—Epirubicin—testicular cancer	0.000105	0.000385	CcSEcCtD
Pantoprazole—Discomfort—Methotrexate—testicular cancer	0.000105	0.000383	CcSEcCtD
Pantoprazole—Nervousness—Doxorubicin—testicular cancer	0.000105	0.000383	CcSEcCtD
Pantoprazole—Vertigo—Epirubicin—testicular cancer	0.000105	0.000383	CcSEcCtD
Pantoprazole—Syncope—Epirubicin—testicular cancer	0.000105	0.000382	CcSEcCtD
Pantoprazole—Leukopenia—Epirubicin—testicular cancer	0.000104	0.000382	CcSEcCtD
Pantoprazole—Back pain—Doxorubicin—testicular cancer	0.000104	0.000382	CcSEcCtD
Pantoprazole—Muscle spasms—Doxorubicin—testicular cancer	0.000104	0.000379	CcSEcCtD
Pantoprazole—Palpitations—Epirubicin—testicular cancer	0.000103	0.000377	CcSEcCtD
Pantoprazole—Confusional state—Methotrexate—testicular cancer	0.000103	0.000375	CcSEcCtD
Pantoprazole—Loss of consciousness—Epirubicin—testicular cancer	0.000103	0.000375	CcSEcCtD
Pantoprazole—Cough—Epirubicin—testicular cancer	0.000102	0.000372	CcSEcCtD
Pantoprazole—Anaphylactic shock—Methotrexate—testicular cancer	0.000102	0.000372	CcSEcCtD
Pantoprazole—Vision blurred—Doxorubicin—testicular cancer	0.000102	0.000372	CcSEcCtD
Pantoprazole—Convulsion—Epirubicin—testicular cancer	0.000101	0.000369	CcSEcCtD
Pantoprazole—Infection—Methotrexate—testicular cancer	0.000101	0.000369	CcSEcCtD
Pantoprazole—Nausea—Etoposide—testicular cancer	0.000101	0.000369	CcSEcCtD
Pantoprazole—Hypertension—Epirubicin—testicular cancer	0.000101	0.000368	CcSEcCtD
Pantoprazole—Ill-defined disorder—Doxorubicin—testicular cancer	0.0001	0.000366	CcSEcCtD
Pantoprazole—Nervous system disorder—Methotrexate—testicular cancer	9.98e-05	0.000365	CcSEcCtD
Pantoprazole—Anaemia—Doxorubicin—testicular cancer	9.98e-05	0.000365	CcSEcCtD
Pantoprazole—Thrombocytopenia—Methotrexate—testicular cancer	9.96e-05	0.000364	CcSEcCtD
Pantoprazole—Myalgia—Epirubicin—testicular cancer	9.93e-05	0.000363	CcSEcCtD
Pantoprazole—Chest pain—Epirubicin—testicular cancer	9.93e-05	0.000363	CcSEcCtD
Pantoprazole—Arthralgia—Epirubicin—testicular cancer	9.93e-05	0.000363	CcSEcCtD
Pantoprazole—Agitation—Doxorubicin—testicular cancer	9.92e-05	0.000363	CcSEcCtD
Pantoprazole—Anxiety—Epirubicin—testicular cancer	9.9e-05	0.000362	CcSEcCtD
Pantoprazole—Skin disorder—Methotrexate—testicular cancer	9.88e-05	0.000361	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	9.86e-05	0.000361	CcSEcCtD
Pantoprazole—Hyperhidrosis—Methotrexate—testicular cancer	9.84e-05	0.00036	CcSEcCtD
Pantoprazole—Discomfort—Epirubicin—testicular cancer	9.81e-05	0.000359	CcSEcCtD
Pantoprazole—Malaise—Doxorubicin—testicular cancer	9.73e-05	0.000356	CcSEcCtD
Pantoprazole—Dry mouth—Epirubicin—testicular cancer	9.71e-05	0.000355	CcSEcCtD
Pantoprazole—Vertigo—Doxorubicin—testicular cancer	9.7e-05	0.000355	CcSEcCtD
Pantoprazole—Anorexia—Methotrexate—testicular cancer	9.7e-05	0.000355	CcSEcCtD
Pantoprazole—Syncope—Doxorubicin—testicular cancer	9.68e-05	0.000354	CcSEcCtD
Pantoprazole—Leukopenia—Doxorubicin—testicular cancer	9.66e-05	0.000353	CcSEcCtD
Pantoprazole—Confusional state—Epirubicin—testicular cancer	9.6e-05	0.000351	CcSEcCtD
Pantoprazole—Palpitations—Doxorubicin—testicular cancer	9.54e-05	0.000349	CcSEcCtD
Pantoprazole—Anaphylactic shock—Epirubicin—testicular cancer	9.52e-05	0.000348	CcSEcCtD
Pantoprazole—Oedema—Epirubicin—testicular cancer	9.52e-05	0.000348	CcSEcCtD
Pantoprazole—Hypotension—Methotrexate—testicular cancer	9.51e-05	0.000348	CcSEcCtD
Pantoprazole—Loss of consciousness—Doxorubicin—testicular cancer	9.49e-05	0.000347	CcSEcCtD
Pantoprazole—Infection—Epirubicin—testicular cancer	9.46e-05	0.000346	CcSEcCtD
Pantoprazole—Cough—Doxorubicin—testicular cancer	9.42e-05	0.000344	CcSEcCtD
Pantoprazole—Shock—Epirubicin—testicular cancer	9.37e-05	0.000342	CcSEcCtD
Pantoprazole—Convulsion—Doxorubicin—testicular cancer	9.35e-05	0.000342	CcSEcCtD
Pantoprazole—Nervous system disorder—Epirubicin—testicular cancer	9.34e-05	0.000341	CcSEcCtD
Pantoprazole—Thrombocytopenia—Epirubicin—testicular cancer	9.32e-05	0.000341	CcSEcCtD
Pantoprazole—Hypertension—Doxorubicin—testicular cancer	9.32e-05	0.000341	CcSEcCtD
Pantoprazole—Tachycardia—Epirubicin—testicular cancer	9.29e-05	0.00034	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Methotrexate—testicular cancer	9.27e-05	0.000339	CcSEcCtD
Pantoprazole—Skin disorder—Epirubicin—testicular cancer	9.25e-05	0.000338	CcSEcCtD
Pantoprazole—Hyperhidrosis—Epirubicin—testicular cancer	9.2e-05	0.000336	CcSEcCtD
Pantoprazole—Insomnia—Methotrexate—testicular cancer	9.2e-05	0.000336	CcSEcCtD
Pantoprazole—Myalgia—Doxorubicin—testicular cancer	9.19e-05	0.000336	CcSEcCtD
Pantoprazole—Chest pain—Doxorubicin—testicular cancer	9.19e-05	0.000336	CcSEcCtD
Pantoprazole—Arthralgia—Doxorubicin—testicular cancer	9.19e-05	0.000336	CcSEcCtD
Pantoprazole—Anxiety—Doxorubicin—testicular cancer	9.16e-05	0.000335	CcSEcCtD
Pantoprazole—Paraesthesia—Methotrexate—testicular cancer	9.14e-05	0.000334	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	9.13e-05	0.000334	CcSEcCtD
Pantoprazole—Discomfort—Doxorubicin—testicular cancer	9.08e-05	0.000332	CcSEcCtD
Pantoprazole—Anorexia—Epirubicin—testicular cancer	9.08e-05	0.000332	CcSEcCtD
Pantoprazole—Dyspnoea—Methotrexate—testicular cancer	9.07e-05	0.000332	CcSEcCtD
Pantoprazole—Somnolence—Methotrexate—testicular cancer	9.04e-05	0.000331	CcSEcCtD
Pantoprazole—Dry mouth—Doxorubicin—testicular cancer	8.99e-05	0.000329	CcSEcCtD
Pantoprazole—Dyspepsia—Methotrexate—testicular cancer	8.96e-05	0.000327	CcSEcCtD
Pantoprazole—Hypotension—Epirubicin—testicular cancer	8.9e-05	0.000325	CcSEcCtD
Pantoprazole—Confusional state—Doxorubicin—testicular cancer	8.88e-05	0.000325	CcSEcCtD
Pantoprazole—Decreased appetite—Methotrexate—testicular cancer	8.84e-05	0.000323	CcSEcCtD
Pantoprazole—Oedema—Doxorubicin—testicular cancer	8.81e-05	0.000322	CcSEcCtD
Pantoprazole—Anaphylactic shock—Doxorubicin—testicular cancer	8.81e-05	0.000322	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Methotrexate—testicular cancer	8.78e-05	0.000321	CcSEcCtD
Pantoprazole—Fatigue—Methotrexate—testicular cancer	8.77e-05	0.000321	CcSEcCtD
Pantoprazole—Infection—Doxorubicin—testicular cancer	8.75e-05	0.00032	CcSEcCtD
Pantoprazole—Pain—Methotrexate—testicular cancer	8.7e-05	0.000318	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Epirubicin—testicular cancer	8.67e-05	0.000317	CcSEcCtD
Pantoprazole—Shock—Doxorubicin—testicular cancer	8.67e-05	0.000317	CcSEcCtD
Pantoprazole—Nervous system disorder—Doxorubicin—testicular cancer	8.64e-05	0.000316	CcSEcCtD
Pantoprazole—Thrombocytopenia—Doxorubicin—testicular cancer	8.63e-05	0.000315	CcSEcCtD
Pantoprazole—Insomnia—Epirubicin—testicular cancer	8.61e-05	0.000315	CcSEcCtD
Pantoprazole—Tachycardia—Doxorubicin—testicular cancer	8.6e-05	0.000314	CcSEcCtD
Pantoprazole—Skin disorder—Doxorubicin—testicular cancer	8.56e-05	0.000313	CcSEcCtD
Pantoprazole—Paraesthesia—Epirubicin—testicular cancer	8.55e-05	0.000313	CcSEcCtD
Pantoprazole—Hyperhidrosis—Doxorubicin—testicular cancer	8.52e-05	0.000311	CcSEcCtD
Pantoprazole—Dyspnoea—Epirubicin—testicular cancer	8.49e-05	0.00031	CcSEcCtD
Pantoprazole—Somnolence—Epirubicin—testicular cancer	8.46e-05	0.000309	CcSEcCtD
Pantoprazole—Anorexia—Doxorubicin—testicular cancer	8.4e-05	0.000307	CcSEcCtD
Pantoprazole—Feeling abnormal—Methotrexate—testicular cancer	8.38e-05	0.000306	CcSEcCtD
Pantoprazole—Dyspepsia—Epirubicin—testicular cancer	8.38e-05	0.000306	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Methotrexate—testicular cancer	8.32e-05	0.000304	CcSEcCtD
Pantoprazole—Decreased appetite—Epirubicin—testicular cancer	8.28e-05	0.000303	CcSEcCtD
Pantoprazole—Hypotension—Doxorubicin—testicular cancer	8.23e-05	0.000301	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Epirubicin—testicular cancer	8.22e-05	0.0003	CcSEcCtD
Pantoprazole—Fatigue—Epirubicin—testicular cancer	8.21e-05	0.0003	CcSEcCtD
Pantoprazole—Pain—Epirubicin—testicular cancer	8.14e-05	0.000298	CcSEcCtD
Pantoprazole—Constipation—Epirubicin—testicular cancer	8.14e-05	0.000298	CcSEcCtD
Pantoprazole—Urticaria—Methotrexate—testicular cancer	8.08e-05	0.000295	CcSEcCtD
Pantoprazole—Body temperature increased—Methotrexate—testicular cancer	8.04e-05	0.000294	CcSEcCtD
Pantoprazole—Abdominal pain—Methotrexate—testicular cancer	8.04e-05	0.000294	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Doxorubicin—testicular cancer	8.03e-05	0.000293	CcSEcCtD
Pantoprazole—Insomnia—Doxorubicin—testicular cancer	7.97e-05	0.000291	CcSEcCtD
Pantoprazole—Paraesthesia—Doxorubicin—testicular cancer	7.91e-05	0.000289	CcSEcCtD
Pantoprazole—Dyspnoea—Doxorubicin—testicular cancer	7.85e-05	0.000287	CcSEcCtD
Pantoprazole—Feeling abnormal—Epirubicin—testicular cancer	7.85e-05	0.000287	CcSEcCtD
Pantoprazole—Somnolence—Doxorubicin—testicular cancer	7.83e-05	0.000286	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Epirubicin—testicular cancer	7.79e-05	0.000285	CcSEcCtD
Pantoprazole—Dyspepsia—Doxorubicin—testicular cancer	7.75e-05	0.000283	CcSEcCtD
Pantoprazole—Decreased appetite—Doxorubicin—testicular cancer	7.66e-05	0.00028	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Doxorubicin—testicular cancer	7.61e-05	0.000278	CcSEcCtD
Pantoprazole—Fatigue—Doxorubicin—testicular cancer	7.6e-05	0.000278	CcSEcCtD
Pantoprazole—Urticaria—Epirubicin—testicular cancer	7.56e-05	0.000276	CcSEcCtD
Pantoprazole—Pain—Doxorubicin—testicular cancer	7.53e-05	0.000275	CcSEcCtD
Pantoprazole—Constipation—Doxorubicin—testicular cancer	7.53e-05	0.000275	CcSEcCtD
Pantoprazole—Body temperature increased—Epirubicin—testicular cancer	7.53e-05	0.000275	CcSEcCtD
Pantoprazole—Abdominal pain—Epirubicin—testicular cancer	7.53e-05	0.000275	CcSEcCtD
Pantoprazole—Hypersensitivity—Methotrexate—testicular cancer	7.5e-05	0.000274	CcSEcCtD
Pantoprazole—Asthenia—Methotrexate—testicular cancer	7.3e-05	0.000267	CcSEcCtD
Pantoprazole—Feeling abnormal—Doxorubicin—testicular cancer	7.26e-05	0.000265	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Doxorubicin—testicular cancer	7.2e-05	0.000263	CcSEcCtD
Pantoprazole—Pruritus—Methotrexate—testicular cancer	7.2e-05	0.000263	CcSEcCtD
Pantoprazole—Hypersensitivity—Epirubicin—testicular cancer	7.01e-05	0.000256	CcSEcCtD
Pantoprazole—Urticaria—Doxorubicin—testicular cancer	7e-05	0.000256	CcSEcCtD
Pantoprazole—Abdominal pain—Doxorubicin—testicular cancer	6.96e-05	0.000255	CcSEcCtD
Pantoprazole—Body temperature increased—Doxorubicin—testicular cancer	6.96e-05	0.000255	CcSEcCtD
Pantoprazole—Diarrhoea—Methotrexate—testicular cancer	6.96e-05	0.000254	CcSEcCtD
Pantoprazole—Asthenia—Epirubicin—testicular cancer	6.83e-05	0.00025	CcSEcCtD
Pantoprazole—Pruritus—Epirubicin—testicular cancer	6.74e-05	0.000246	CcSEcCtD
Pantoprazole—Dizziness—Methotrexate—testicular cancer	6.73e-05	0.000246	CcSEcCtD
Pantoprazole—Diarrhoea—Epirubicin—testicular cancer	6.51e-05	0.000238	CcSEcCtD
Pantoprazole—Hypersensitivity—Doxorubicin—testicular cancer	6.49e-05	0.000237	CcSEcCtD
Pantoprazole—Vomiting—Methotrexate—testicular cancer	6.47e-05	0.000236	CcSEcCtD
Pantoprazole—Rash—Methotrexate—testicular cancer	6.41e-05	0.000234	CcSEcCtD
Pantoprazole—Dermatitis—Methotrexate—testicular cancer	6.41e-05	0.000234	CcSEcCtD
Pantoprazole—Headache—Methotrexate—testicular cancer	6.37e-05	0.000233	CcSEcCtD
Pantoprazole—Asthenia—Doxorubicin—testicular cancer	6.32e-05	0.000231	CcSEcCtD
Pantoprazole—Dizziness—Epirubicin—testicular cancer	6.3e-05	0.00023	CcSEcCtD
Pantoprazole—Pruritus—Doxorubicin—testicular cancer	6.23e-05	0.000228	CcSEcCtD
Pantoprazole—Vomiting—Epirubicin—testicular cancer	6.05e-05	0.000221	CcSEcCtD
Pantoprazole—Nausea—Methotrexate—testicular cancer	6.04e-05	0.000221	CcSEcCtD
Pantoprazole—Diarrhoea—Doxorubicin—testicular cancer	6.03e-05	0.00022	CcSEcCtD
Pantoprazole—Rash—Epirubicin—testicular cancer	6e-05	0.000219	CcSEcCtD
Pantoprazole—Dermatitis—Epirubicin—testicular cancer	6e-05	0.000219	CcSEcCtD
Pantoprazole—Headache—Epirubicin—testicular cancer	5.96e-05	0.000218	CcSEcCtD
Pantoprazole—Dizziness—Doxorubicin—testicular cancer	5.83e-05	0.000213	CcSEcCtD
Pantoprazole—Nausea—Epirubicin—testicular cancer	5.66e-05	0.000207	CcSEcCtD
Pantoprazole—Vomiting—Doxorubicin—testicular cancer	5.6e-05	0.000205	CcSEcCtD
Pantoprazole—Rash—Doxorubicin—testicular cancer	5.55e-05	0.000203	CcSEcCtD
Pantoprazole—Dermatitis—Doxorubicin—testicular cancer	5.55e-05	0.000203	CcSEcCtD
Pantoprazole—Headache—Doxorubicin—testicular cancer	5.52e-05	0.000202	CcSEcCtD
Pantoprazole—Nausea—Doxorubicin—testicular cancer	5.23e-05	0.000191	CcSEcCtD
